InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Lurker Nancy, Chairman & CEO. Director active across 4 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 29 disclosures have been logged. Breakdown: 1 buy · 6 sells. Total volume traded: €957k. Activity tracked since 14 June 2021. The latest transaction was filed on 21 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lurker Nancy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
6,142 sharesOrdinary SharesSEC:0001520262-26-000089:0
1,475 shares@ US$36.950.0010% mcap100.0% of flowOrdinary SharesSEC:0001520262-26-000089:1
4,500 shares@ US$35.96910.0094% mcap50.0% of flowCommon StockSEC:0001450485-26-000007:0
3,751 sharesOrdinary SharesSEC:0001520262-26-000070:0
901 shares@ US$33.360.0003% mcap35.4% of flowOrdinary SharesSEC:0001520262-26-000070:1
75,133 shares0Common StockSEC:0001450485-26-000005:0
12,666 shares0Common StockSEC:0001450485-26-000003:0
9,300 shares@ US$15.105114.7% of flowCommon StockSEC:0001450485-25-000009:0
200 shares@ US$14.950.4% of flowCommon StockSEC:0001450485-25-000007:0
11,111 shares0Common StockSEC:0001562180-25-005390:0
8,013 sharesOrdinary SharesSEC:0001127602-25-016202:0
9,791 shares0Common StockSEC:0001062993-25-009809:0
2,323 sharesOrdinary SharesSEC:0001127602-25-012018:0
20,000 shares0Common StockSEC:0001562180-25-001134:0
12,726 shares0Common StockSEC:0001062993-25-001754:0
12,667 shares0Common StockSEC:0001562180-25-000228:0
3,173 shares@ US$7.882.6% of flowCommon StockSEC:0001562180-24-006378:0
Canonical exit: 14 Nov 2024 (T+90)
11,111 shares0Common StockSEC:0001562180-24-005700:0
20,000 shares0Common StockSEC:0001562180-24-001294:0
5,044 shares@ US$24.970213.3% of flowCommon StockSEC:0001562180-24-000636:0
75,133 shares0Common StockSEC:0001562180-24-000402:0
52,208 shares0Common StockSEC:0001562180-24-000133:0
20,000 shares@ US$20.7643.7% of flowCommon StockSEC:0001562180-23-008170:0
17,533 shares0Common StockSEC:0001562180-23-001330:0
12,466 shares0Common StockSEC:0001562180-22-002135:0
25 of 29 declarations
About Lurker Nancy
Lurker Nancy is Président-Directeur Général. She has 29 filings in total, and across the recent sample of 29 filings, the reported buy amount is EUR 22787 and the reported sell amount is EUR 934332, with a date range from 2021-06-15 to 2026-05-22. The modal transaction nature is Levée d'options; among the recent filings are transactions involving EyePoint Pharmaceuticals, Inc., COLLEGIUM PHARMACEUTICAL, INC and Alkermes plc.
